A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : EP / etoposide-platinum

[Related PubMed/MEDLINE]
Total Number of Papers: 16
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   EP  (>> Co-occurring Abbreviation)
Long Form:   etoposide-platinum
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A multi-center retrospective study of neuroendocrine tumors of the uterine cervix: Prognosis according to the new 2018 staging system, comparing outcomes for different chemotherapeutic regimens and histopathological subtypes. FIGO, HGNEC, NETs
2018 Advances in antibody therapeutics targeting small-cell lung cancer. IGF-1R, PFS, SCLC
2018 Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts. CTC, PDX, SCLC
2018 Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study. CI, DFS, FIGO, HGNEC, HR, OS
2018 The efficacy of chemotherapy and operation in patients with colorectal neuroendocrine carcinoma. 5-FU, CI, CRNEC, CSS, HR, OS
2017 Comparison of irinotecan/platinum versus etoposide/platinum chemotherapy for extensive-stage small cell lung cancer: A meta-analysis. CI, E-SCLC, HR, IP, OR, OS, RR
2017 Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix. RFS, SCNEC
2017 The impact of pathologic differentiation (well/poorly) and the degree of Ki-67 index in patients with metastatic WHO grade 3 GEP-NECs. PD, WD
2016 Irinotecan compared with etoposide in combination with platinum in previously untreated extensive stage small cell lung cancer: An updated systemic review. HR, IP, OR
10  2015 Benefit from ifosfamide treatment in small-cell lung cancer: A meta-analysis. CI, IEP, RR, SCLC
11  2010 A meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer. CI, E-SCLC, HRs, IP, OS, PFS
12  2009 [Aidi Injection as an adjunct therapy for non-small cell lung cancer: a systematic review]. CI, NP, NSCLC, RR, TP
13  2004 [Clinical experience with chemotherapy of the malignant tumor of germinal cells (dysgerminoma) of the ovary]. BEP
14  2000 A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party. CI
15  1998 Optimal duration of chemotherapy in small cell lung cancer: a randomized study of 4 versus 6 cycles of cisplatin-etoposide. ---
16  1992 Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. SRT